42 U.S.C. § 242 | Studies and investigations on use and misuse of narcotic drugs and other drugs; annual report to Attorney General; cooperation with States

(a)

section 241 of this title 21 U.S.C. 801 21 U.S.C. 951 In carrying out the purposes of with respect to drugs the use or misuse of which might result in drug abuse or dependency, the studies and investigations authorized therein shall include the use and misuse of narcotic drugs and other drugs. Such studies and investigations shall further include the quantities of crude opium, coca leaves, and their salts, derivatives, and preparations, and other drugs subject to control under the Controlled Substances Act [ et seq.] and Controlled Substances Import and Export Act [ et seq.], together with reserves thereof, necessary to supply the normal and emergency medicinal and scientific requirements of the United States. The results of studies and investigations of the quantities of narcotic drugs or other drugs subject to control under such Acts, together with reserves of such drugs, that are necessary to supply the normal and emergency medicinal and scientific requirements of the United States, shall be reported not later than the first day of April of each year to the Attorney General, to be used at his discretion in determining manufacturing quotas or importation requirements under such Acts.

(b)

The Surgeon General shall cooperate with States for the purpose of aiding them to solve their narcotic drug problems and shall give authorized representatives of the States the benefit of his experience in the care, treatment, and rehabilitation of narcotic addicts to the end that each State may be encouraged to provide adequate facilities and methods for the care and treatment of its narcotic addicts.

July 1, 1944, ch. 373 58 Stat. 692 Pub. L. 91–513, title II, § 701(j)Oct. 27, 197084 Stat. 1282 (, title III, § 302, ; , , .)

Editorial Notes

References in Text

Pub. L. 91–513Oct. 27, 197084 Stat. 1242 section 801 of Title 21The Controlled Substances Act, referred to in subsec. (a), is title II of , , , which is classified principally to subchapter I (§ 801 et seq.) of chapter 13 of Title 21, Food and Drugs. For complete classification of this Act to the Code, see Short Title note set out under and Tables.

Pub. L. 91–513Oct. 27, 197084 Stat. 1285 section 951 of Title 21The Controlled Substances Import and Export Act, referred to in subsec. (a), is title III of , , , which is classified principally to subchapter II (§ 951 et seq.) of chapter 13 of Title 21. For complete classification of this Act to the Code, see Short Title note set out under and Tables.

Amendments

Pub. L. 91–5131970—Subsec. (a). inserted references to drug dependency, drugs other than narcotic drugs, and substances subject to control under the Controlled Substances Act and the Controlled Substances Import and Export Act, substituted the first day of April of each year for the first day of September of each year as the date by which the study results must be submitted, substituted the Attorney General for the Secretary of the Treasury as the officer to whom the report is to be submitted, and struck out references to the Narcotic Drugs Import and Export Act.

Statutory Notes and Related Subsidiaries

Change of Name

section 509(b) of Pub. L. 96–88 section 3508(b) of Title 20“Secretary of Health and Human Services” substituted for “Secretary of Health, Education, and Welfare” pursuant to , which is classified to , Education.

Effective Date of 1970 Amendment

Pub. L. 91–513Oct. 26, 1970section 704 of Pub. L. 91–513 section 801 of Title 21Amendment by effective on first day of seventh calendar month that begins after , see , set out as an Effective Date note under , Food and Drugs.

Savings Provision

Pub. L. 91–513Oct. 27, 1970Oct. 27, 1970section 702 of Pub. L. 91–513 section 321 of Title 21Amendment by not to affect or abate any prosecutions for violation of law or any civil seizures or forfeitures and injunctive proceedings commenced prior to the effective date of such amendment, and all administrative proceedings pending before the Bureau of Narcotics and Dangerous Drugs on , to be continued and brought to final determination in accord with laws and regulations in effect prior to , see , set out as a note under , Food and Drugs.

Marihuana and Health Reporting

Pub. L. 91–296, title VJune 30, 197084 Stat. 352 Pub. L. 95–461, § 3(a)Oct. 14, 197892 Stat. 1268 Pub. L. 96–88, title V, § 509(b)Oct. 17, 197993 Stat. 695 January 31, 1971Pub. L. 98–24, § 2(d)Apr. 26, 198397 Stat. 182 , , , as amended by , , ; , , , known as the Marihuana and Health Reporting Act, which required the Secretary of Health and Human Services, after consultation with the Surgeon General and other appropriate individuals, to transmit a report to the Congress on or before , and biennially thereafter (1) containing current information on the health consequences of using marihuana, and (2) containing such recommendations for legislative and administrative action as he may deem appropriate, was repealed by , , .

Executive Documents

Transfer of Functions

June 25, 196680 Stat. 1610 section 202 of this titleMar. 30, 1987Office of Surgeon General abolished by section 3 of Reorg. Plan No. 3 of 1966, eff. , 31 F.R. 8855, , and functions thereof transferred to Secretary of Health, Education, and Welfare by section 1 of Reorg. Plan No. 3 of 1966, set out as a note under . Office of Surgeon General reestablished within the Office of the Assistant Secretary for Health, see Notice of Department of Health and Human Services, Office of the Assistant Secretary for Health, , 52 F.R. 11754.